Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features.
Bielle F, Di Stefano AL, Meyronet D, Picca A, Villa C, Bernier M, Schmitt Y, Giry M, Rousseau A, Figarella-Branger D, Maurage CA, Uro-Coste E, Lasorella A, Iavarone A, Sanson M, Mokhtari K. Bielle F, et al. Among authors: meyronet d. Brain Pathol. 2018 Sep;28(5):674-683. doi: 10.1111/bpa.12563. Epub 2017 Nov 21. Brain Pathol. 2018. PMID: 28976058 Free PMC article.
Electron microscopy in neuromuscular disorders.
Fernandez C, Figarella-Branger D, Meyronet D, Cassote E, Tong S, Pellissier JF. Fernandez C, et al. Among authors: meyronet d. Ultrastruct Pathol. 2005 Nov-Dec;29(6):437-50. doi: 10.1080/01913120500323175. Ultrastruct Pathol. 2005. PMID: 16316944 Review.
[Virtual slides, yes, virtual pathologists, no!].
Figarella-Branger D, Meyronet D. Figarella-Branger D, et al. Among authors: meyronet d. Med Sci (Paris). 2012 Nov;28(11):907-8. doi: 10.1051/medsci/20122811001. Epub 2012 Nov 12. Med Sci (Paris). 2012. PMID: 23171886 Free article. French. No abstract available.
Molecular heterogeneity of glioblastomas: does location matter?
Denicolaï E, Tabouret E, Colin C, Metellus P, Nanni I, Boucard C, Tchoghandjian A, Meyronet D, Baeza-Kallee N, Chinot O, Figarella-Branger D. Denicolaï E, et al. Among authors: meyronet d. Oncotarget. 2016 Jan 5;7(1):902-13. doi: 10.18632/oncotarget.6433. Oncotarget. 2016. PMID: 26637806 Free PMC article.
Characteristics of gliomas in patients with somatic IDH mosaicism.
Bonnet C, Thomas L, Psimaras D, Bielle F, Vauléon E, Loiseau H, Cartalat-Carel S, Meyronet D, Dehais C, Honnorat J, Sanson M, Ducray F. Bonnet C, et al. Among authors: meyronet d. Acta Neuropathol Commun. 2016 Mar 31;4:31. doi: 10.1186/s40478-016-0302-y. Acta Neuropathol Commun. 2016. PMID: 27036230 Free PMC article.
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
Tabouret E, Nguyen AT, Dehais C, Carpentier C, Ducray F, Idbaih A, Mokhtari K, Jouvet A, Uro-Coste E, Colin C, Chinot O, Loiseau H, Moyal E, Maurage CA, Polivka M, Lechapt-Zalcman E, Desenclos C, Meyronet D, Delattre JY, Figarella-Branger D; For POLA Network. Tabouret E, et al. Among authors: meyronet d. Acta Neuropathol. 2016 Oct;132(4):625-34. doi: 10.1007/s00401-016-1611-8. Epub 2016 Aug 29. Acta Neuropathol. 2016. PMID: 27573687
Characteristics of H3 K27M-mutant gliomas in adults.
Meyronet D, Esteban-Mader M, Bonnet C, Joly MO, Uro-Coste E, Amiel-Benouaich A, Forest F, Rousselot-Denis C, Burel-Vandenbos F, Bourg V, Guyotat J, Fenouil T, Jouvet A, Honnorat J, Ducray F. Meyronet D, et al. Neuro Oncol. 2017 Aug 1;19(8):1127-1134. doi: 10.1093/neuonc/now274. Neuro Oncol. 2017. PMID: 28201752 Free PMC article.
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.
Quillien V, Lavenu A, Ducray F, Meyronet D, Chinot O, Fina F, Sanson M, Carpentier C, Karayan-Tapon L, Rivet P, Entz-Werle N, Legrain M, Zalcman EL, Levallet G, Escande F, Ramirez C, Chiforeanu D, Vauleon E, Figarella-Branger D. Quillien V, et al. Among authors: meyronet d. Cancer Biomark. 2017 Dec 6;20(4):435-441. doi: 10.3233/CBM-170191. Cancer Biomark. 2017. PMID: 28800313 Free article.
146 results